SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 105.40-2.6%Nov 13 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (1176)9/21/1999 12:14:00 PM
From: LLCF  Read Replies (1) of 3202
 
They're pumping their new offering:

The Silicon Valley-based firm has just launched its ''In Silico Partnership Program'' which will provide select academic investigators with collaborative access to Incyte's genomic databases, microarrays, reagents, and software products that are currently used in all phases of drug discovery and development. Its alliance with the Huntsman Cancer Institute was announced earlier this month and will focus on the genetic study of colon cancer in families with a high risk of developing the disease. Huntsman will use Incyte's state-of-the art microarray technology as well as the LifeSeq® Gold
database.

I'll give a call and see what type of deal they are structuring.. I recall that they said at their conference call that they would structure all sorts of deals depending on the subscriber, and what they could afford. In other words, this deal is probably back-end royalty... and very little upfront.

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News